Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ANDREW J BISHOP and BEHRANG AMINI.
ANDREW J BISHOP
Connection Strength
1.872
BEHRANG AMINI
  1. Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk. Radiother Oncol. 2024 04; 193:110119.
    View in: PubMed
    Score: 0.237
  2. Advances in the management of spinal metastases: what the radiologist needs to know. Br J Radiol. 2023 Jan 01; 96(1141):20220267.
    View in: PubMed
    Score: 0.214
  3. Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma. J Immunother. 2022 10 01; 45(8):374-378.
    View in: PubMed
    Score: 0.213
  4. Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations. J Neurosurg Spine. 2017 Sep; 27(3):303-311.
    View in: PubMed
    Score: 0.150
  5. Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1016-1026.
    View in: PubMed
    Score: 0.128
  6. Validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic body radiation. Radiother Oncol. 2024 Oct 02; 201:110570.
    View in: PubMed
    Score: 0.062
  7. Spinal laser interstitial thermal therapy and radiotherapy for thoracic metastatic epidural spinal cord compression. J Neurooncol. 2024 Nov; 170(2):289-296.
    View in: PubMed
    Score: 0.062
  8. Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response. Sci Rep. 2024 09 17; 14(1):21681.
    View in: PubMed
    Score: 0.062
  9. Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery. J Neurooncol. 2023 Sep; 164(2):377-386.
    View in: PubMed
    Score: 0.057
  10. Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases. Radiat Oncol J. 2023 Mar; 41(1):12-22.
    View in: PubMed
    Score: 0.056
  11. Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases. Pract Radiat Oncol. 2023 Jan-Feb; 13(1):e7-e13.
    View in: PubMed
    Score: 0.054
  12. Clinical activity of checkpoint inhibitors in angiosarcoma: A retrospective cohort study. Cancer. 2022 09 15; 128(18):3383-3391.
    View in: PubMed
    Score: 0.053
  13. Spinal laser interstitial thermal therapy: single-center experience and outcomes in the first 120 cases. J Neurosurg Spine. 2021 03 01; 34(3):354-363.
    View in: PubMed
    Score: 0.048
  14. Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgery. Radiother Oncol. 2020 11; 152:49-55.
    View in: PubMed
    Score: 0.046
  15. Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol. 2020 Jun; 148(2):327-334.
    View in: PubMed
    Score: 0.046
  16. Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience. J Neurosurg Spine. 2020 06 01; 32(6):941-949.
    View in: PubMed
    Score: 0.045
  17. A comparison of spinal laser interstitial thermotherapy with open surgery for metastatic thoracic epidural spinal cord compression. J Neurosurg Spine. 2020 05 01; 32(5):667-675.
    View in: PubMed
    Score: 0.045
  18. Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up. Radiother Oncol. 2019 09; 138:80-85.
    View in: PubMed
    Score: 0.043
  19. Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery. Pract Radiat Oncol. 2019 Mar; 9(2):e142-e148.
    View in: PubMed
    Score: 0.041
  20. Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1207-1215.
    View in: PubMed
    Score: 0.038
  21. A Novel Use of the Intraoperative MRI for Metastatic Spine Tumors: Laser Interstitial Thermal Therapy for Percutaneous Treatment of Epidural Metastatic Spine Disease. Neurosurg Clin N Am. 2017 Oct; 28(4):513-524.
    View in: PubMed
    Score: 0.038
  22. Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery. J Radiosurg SBRT. 2017; 5(1):25-34.
    View in: PubMed
    Score: 0.036
  23. Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials. Int J Radiat Oncol Biol Phys. 2016 08 01; 95(5):1405-1413.
    View in: PubMed
    Score: 0.034
  24. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. J Neurosurg Spine. 2016 May; 24(5):829-36.
    View in: PubMed
    Score: 0.034
  25. Creation of a Prognostic Index for Spine Metastasis to Stratify Survival in Patients Treated With Spinal Stereotactic Radiosurgery: Secondary Analysis of Mature Prospective Trials. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):118-25.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.